Nasseo, Inc.

Nasseo, Inc. is a medical device company that has developed next generation dental/orthopedic implants that incorporate our proprietary implant surface modification nanotechnology. Nasseo’s platform nanotechnology alters the implant surface at the molecular level to enhance osseointegration, enhance bone cell growth and differentiation, and lower inflammation. Nasseo’s first product, the TiArray™ Dental Implant system, recently received FDA 510(k) regulatory approval. Nasseo’s second product is a PEEK based spinal cage implant system that incorporates Nasseo’s platform technology and is currently in product development. Nasseo has raised $1.5M in grant funding and ~$800K in seed funding to date and is seeking a ~$1M Series A round to cover clinical trials starting in Q1 2014.

Nasseo’s milestones thus far include winning both the 2012 UCSD Entrepreneur Challenge Executive Summary & Business Plan competitions, being selected to the 2012 World’s Best Technology (WBT) and the 2013 National Innovation Showcases, winning the 2013 CONNECT Life Sciences Capital Competition, closing a $520K seed round led by a leading dentist and the BioAccel/BioInspire medtech incubator, winning the 2013 $250K Arizona Innovation Challenge, being selected as one of thirty 2013 SDVG Cool Companies, being selected to the 2013 NCET2 Global 1000 and the Rocky Mountain Life Science Investor and Partnering Conferences, and receiving a 2013 AZBio Fast Lane award.

Company’s Keywords:

healthcare, medical devices, orthopedic implants, dental implants, surface modification, spinal implants